Unknown

Dataset Information

0

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.


ABSTRACT: Hypoxia is frequently encountered in tumors and results in the stabilization of hypoxia inducible factors (HIFs). These factors transcriptionally activate genes that allow cells to adapt to hypoxia. In cancers, hypoxia and HIFs have been associated with increased invasion, metastasis, and resistance to chemo and radiation therapy. Here we have characterized the metabolic consequences of silencing HIF-1? and HIF-2? singly or combined in MDA-MB-231 triple negative human breast cancer xenografts, using non-invasive proton magnetic resonance spectroscopic imaging (1H MRSI) of in vivo tumors, and high-resolution 1H MRS of tumor extracts. Tumors from all three sublines showed a significant reduction of growth rate. We identified new metabolic targets of HIF, and demonstrated the divergent consequences of silencing HIF-1? and HIF-2? individually on some of these targets. These data expand our understanding of the metabolic pathways regulated by HIFs that may provide new insights into the adaptive metabolic response of cancer cells to hypoxia. Such insights may lead to novel metabolism based therapeutic targets for triple negative breast cancer.

SUBMITTER: Bharti SK 

PROVIDER: S-EPMC5880607 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.

Bharti Santosh K SK   Mironchik Yelena Y   Wildes Flonne F   Penet Marie-France MF   Goggins Eibhlin E   Krishnamachary Balaji B   Bhujwalla Zaver M ZM  

Oncotarget 20180224 20


Hypoxia is frequently encountered in tumors and results in the stabilization of hypoxia inducible factors (HIFs). These factors transcriptionally activate genes that allow cells to adapt to hypoxia. In cancers, hypoxia and HIFs have been associated with increased invasion, metastasis, and resistance to chemo and radiation therapy. Here we have characterized the metabolic consequences of silencing HIF-1α and HIF-2α singly or combined in MDA-MB-231 triple negative human breast cancer xenografts, u  ...[more]

Similar Datasets

| S-EPMC7136496 | biostudies-literature
| S-ECPF-GEOD-47079 | biostudies-other
| S-EPMC5522326 | biostudies-literature
| S-EPMC5568171 | biostudies-literature
| S-EPMC5948145 | biostudies-literature
| S-EPMC9319388 | biostudies-literature
| S-EPMC6407287 | biostudies-literature
| S-EPMC7503243 | biostudies-literature
| S-EPMC8110995 | biostudies-literature
| S-EPMC8152779 | biostudies-literature